CytRx Corp. buy melinda
Start price
13.06.17
/
50%
€3.13
Target price
22.06.17
€3.79
Performance (%)
21.80%
End price
22.06.17
€3.82
Summary
This prediction ended on 22.06.17 with a price of €3.82. The prediction had a final performance of 21.80%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| CytRx Corp. | - | - | - | - |
| iShares Core DAX® | -1,86 % | 0,67 % | 0,92 % | 51,85 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % | 33,72 % | 86,85 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % | 52,96 % | 63,32 % |
| iShares S&P 500 | -1,31 % | 3,40 % | 24,67 % | 66,11 % |
Comments by melinda for this prediction
In the thread CytRx Corp. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
